Menu

Further Support for Early-Life Allergen Exposure

Egg and peanut consumption during infancy is linked to lower risk of allergy to those foods later in life, according to a meta-analysis.

Sep 20, 2016
Jef Akst

WIKIMEDIA, MR.ATOZAnalyzing data from 146 studies involving more than 200,000 children, researchers from Imperial College London have found additional evidence for the recent hypothesis that exposing young children to certain foods might reduce their risk of allergies to those foods. Specifically, the authors of this UK Food Standards Agency–commissioned meta-analysis found that babies fed eggs and peanuts had lower risk of egg and peanut allergies as children. On the other hand, the researchers did not find sufficient support for a similar conclusion regarding milk, fish (including shellfish), nuts, and wheat. The results, published today (September 20) in JAMA, support the growing realization that recommendations to delay babies’ exposure to some allergenic foods may be harmful.

“This study . . .  is more evidence shedding light on the fact that early introduction in the right children can prevent allergies,” Purvi Parikh, an allergist at New York University Langone Medical Center who was not involved in the present study, told New York Daily News.

“The rigorous, comprehensive meta-analysis . . . is an important addition to the evidence regarding food allergy prevention,” Matthew Greenhawt of Children’s Hospital Colorado wrote in an accompanying editorial. “Their conclusions highlight that the 2008 guidelines to not delay introduction were correct.”

In February 2015, an international team of researchers found that infants at high risk of peanut allergies were less likely to develop the allergy if they were exposed to the food early on. Last year, a follow-up study supported this conclusion: even kids who did not eat peanuts for a year were far less likely to be allergic had they regularly consumed peanut-containing foods as babies.

For their meta-analysis, Robert Boyle of Imperial College and colleagues selected data from 146 studies, which they chose from 16,289 related papers. Of these studies, the researchers further selected five (involving 1,915 children) on egg consumption and allergies and two (involving 1,550 children) on the risk of peanut allergy in order to estimate the relative benefit of earlier exposure. They found that children who started eating egg between the ages of 4 and 6 months were 40 percent less likely to develop egg allergies compared with kids who tried egg later in life. Meanwhile, children who ate peanut between the ages of 4 and 11 months had a 70 percent reduced peanut allergy risk, compared with kids who didn’t eat peanuts until they were older, Boyle’s team found.

Based on these numbers, the team further calculated that, for every 1,000 people, 24 cases of egg allergy and 18 cases of peanut allergy could theoretically be prevented by introducing the foods earlier in life. However, the authors cautioned that more research is needed before making such health decisions. “The imprecise effect estimates, issues regarding indirectness, and inconclusive trial sequential analysis findings all need to be considered, together with a careful assessment of the safety and acceptability of early egg and peanut introduction in different populations,” they wrote in their paper.

The researchers found no effect of introducing allergenic foods on babies’ risk of autoimmune diseases such as celiac disease. The evidence that fish introduction before 1 year old reduced risk of fish allergies was weak, and timing of allergenic food introduction was not associated with risk of allergies to those foods. Similarly, the timing of gluten introduction did not appear to be linked with celiac disease risk, the researchers reported. “We were surprised to see no effect for celiac disease, which is a different type of allergy to egg and peanut allergy,” Boyle told Medical News Today. “This suggests that early introduction of allergenic foods does not reduce risk of all types of food allergy.”

“The [UK] Government is considering these important findings as part of its review of complementary feeding for infants to ensure its advice reflects the best available evidence,” the UK Food Standards Agency said in a press release. “Families should continue to follow the Government’s current long-standing advice to exclusively breastfeed for around the first six months of age because of the health benefits to mothers and babies.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.